Cytophage Technologies Ltd. announced that Michael D. Cochrane, a managing partner at Dixford Capital, LLC, has joined the Cytophage board of directors as its newest member. He will also join the Audit and Finance Committee of the board. Michael's extensive experience as an investment banking veteran complements the board's wealth of expertise in research, product development, commercialization, finance and corporate governance.

Michael D. Cochrane is an investment banking veteran with more than 30 years of M&A and finance experience in both New York and Toronto. During his 20-year career in New York, he held coverage and management positions at Goldman, Sachs, Lehman Brothers, Credit Suisse and CIBC World Markets. Michael has specialized in M&A for growth companies focused on industry disruption through unique technologies, innovative business models or consolidation strategies.

Michael is currently the Managing Partner of Dixford Capital, an advisory and investment company which focuses on growing small and mid-sized business through implementing operational, financing and capital allocation strategies. Dixford is presently an investor in Lakeview Mortgage Funding, The Milbrook Corporation, MCC Leasing, Aeris Communications and MacCosham Inc. Previous positions include Managing Director in New York with UBS's Global Industrial Group, Managing Director with CIBC World Markets in Toronto and Co-Head of CIBC's Global Diversified Industries investment banking group. Between 2014 and 2019, Michael taught M&A and Economics courses in the MBA programs at Queen's University's Smith School of Business and York University's Schulich School of Business.